D. Leroux

发表

Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis

Alexander Klistorner, Bernhard Hemmer, Pablo Villoslada, 2017, The Lancet Neurology.

Polymorphisms of protein tyrosine phosphatase CD148 influence FcγRIIA-dependent platelet activation and the risk of heparin-induced thrombocytopenia.

V. Gouilleux-Gruart, B. Payrastre, Y. Gruel, 2012, Blood.

C0343 Polymorphisms of protein tyrosine phosphatase CD148 influence Fcgammariia-dependent platelet activation and the risk of heparin-induced thrombocytopenia

V. Gouilleux-Gruart, B. Payrastre, Y. Gruel, 2012 .

[Heparin-induced thrombocytopenia: recent data].

Y. Gruel, D. Leroux, J. Rollin, 2014, La Revue de medecine interne.

Impact of polymorphisms affecting the ACP1 gene on levels of antibodies against platelet factor 4–heparin complexes

Y. Gruel, M. May, D. Leroux, 2013, Journal of thrombosis and haemostasis : JTH.

Incidence of antibodies to protamine sulfate/heparin complexes in cardiac surgery patients and impact on platelet activation and clinical outcome

Y. Gruel, J. Amiral, M. May, 2013, Thrombosis and Haemostasis.

Binding of heparin‐dependent antibodies to PF4 modified by enoxaparin oligosaccharides: evaluation by surface plasmon resonance and serotonin release assay

Y. Gruel, S. Canépa, D. Leroux, 2012, Journal of thrombosis and haemostasis : JTH.

Increased risk of thrombosis in FcγRIIA 131RR patients with HIT due to defective control of platelet activation by plasma IgG2.

V. Gouilleux-Gruart, Y. Gruel, G. Thibault, 2015, Blood.

Prospective evaluation of a rapid nanoparticle‐based lateral flow immunoassay (STic Expert® HIT) for the diagnosis of heparin‐induced thrombocytopenia

Y. Gruel, A. Lebreton, C. Biron, 2014, British journal of haematology.

PLATELETS AND THROMBOPOIESIS Increased risk of thrombosis in Fc g RIIA 131 RR patients with HIT due to defective control of platelet activation by plasma IgG 2

V. Gouilleux-Gruart, Y. Gruel, G. Thibault, 2015 .

Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources

Tudor Groza, Damian Smedley, Peter N. Robinson, 2018, Nucleic Acids Res..

The need for widely available genomic testing in rare eye diseases: an ERN-EYE position statement

B. Lorenz, D. Fischer, F. Parmeggiani, 2021, Orphanet Journal of Rare Diseases.

Interleukin-10 promoter microsatellite polymorphisms influence the immune response to heparin and the risk of heparin-induced thrombocytopenia.

F. Grigorescu, Y. Gruel, P. Nguyên, 2010, Thrombosis research.

Effectiveness of a new immuno-assay for the diagnosis of heparin-induced thrombocytopenia and improved specificity when detecting IgG antibodies

Y. Gruel, D. Leroux, J. Rollin, 2009, Thrombosis and Haemostasis.

An ontological foundation for ocular phenotypes and rare eye diseases

Rachel Thompson, Peter N Robinson, Annie Olry, 2019, Orphanet Journal of Rare Diseases.

Current management of patients with RPE65 mutation-associated Inherited Retinal Degenerations (RPE65-IRD) in Europe. Results of a 2 years follow-up multinational survey.

K. Stingl, H. Dollfus, H. Scholl, 2023, Ophthalmic research.

Prospective evaluation of a rapid nanoparticle‐based lateral flow immunoassay (STic Expert® HIT) for the diagnosis of heparin‐induced thrombocytopenia

Y. Gruel, A. Lebreton, C. Biron, 2014, British journal of haematology.

Current Management of Inherited Retinal Degeneration Patients in Europe: Results of a 2-Year Follow-Up Multinational Survey by the European Vision Institute Clinical Research Network – EVICR.net

B. Lorenz, P. Charbel Issa, K. Stingl, 2023, Ophthalmic Research.